Percutaneous Transforaminal Endoscopic Discectomy Versus Open Microdiscectomy for Lumbar Disc Herniation: A Systematic Review and Meta-analysis.
Percutaneous Transforaminal Endoscopic Discectomy Versus Open Microdiscectomy for Lumbar Disc Herniation: A Systematic Review and Meta-analysis.
复制标题
经皮经椎间孔内窥镜椎间盘切除术与开放式显微椎间盘切除术治疗腰椎间盘突出症的系统评价和荟萃分析。
DOI:
10.1097/brs.0000000000003843
复制
发表时间:
2021-04-15
期刊:
影响因子:
3
通讯作者:
Rubinstein SM
中科院分区:
文献类型:
--
作者:
Gadjradj PS;Harhangi BS;Amelink J;van Susante J;Kamper S;van Tulder M;Peul WC;Vleggeert-Lankamp C;Rubinstein SM
Supplemental Digital Content is available in the text It is unclear if percutaneous transforaminal endoscopic discectomy (PTED) has comparable outcomes compared with open microdiscectomy (OM). Multiple online databases were systematically searched up to April 2020 for prospective studies. There is moderate quality evidence suggesting no difference in leg pain or functionality at intermediate and long-term follow-up between PTED and OM in the treatment of lumbar disk herniation. Systematic review and meta-analysis. To give a systematic overview of effectiveness of percutaneous transforaminal endoscopic discectomy (PTED) compared with open microdiscectomy (OM) in the treatment of lumbar disk herniation (LDH). The current standard procedure for the treatment of sciatica caused by LDH, is OM. PTED is an alternative surgical technique which is thought to be less invasive. It is unclear if PTED has comparable outcomes compared with OM. Multiple online databases were systematically searched up to April 2020 for randomized controlled trials and prospective studies comparing PTED with OM for LDH. Primary outcomes were leg pain and functional status. Pooled effect estimates were calculated for the primary outcomes only and presented as standard mean differences (SMD) with their 95% confidence intervals (CI) at short (1-day postoperative), intermediate (3–6 months), and long-term (12 months). We identified 2276 citations, of which eventually 14 studies were included. There was substantial heterogeneity in effects on leg pain at short term. There is moderate quality evidence suggesting no difference in leg pain at intermediate (SMD 0.05, 95% CI –0.10–0.21) and long-term follow-up (SMD 0.11, 95% CI –0.30–0.53). Only one study measured functional status at short-term and reported no differences. There is moderate quality evidence suggesting no difference in functional status at intermediate (SMD –0.09, 95% CI –0.24–0.07) and long-term (SMD –0.11, 95% CI –0.45–0.24). There is moderate quality evidence suggesting no difference in leg pain or functional status at intermediate and long-term follow-up between PTED and OM in the treatment of LDH. High quality, robust studies reporting on clinical outcomes and cost-effectiveness on the long term are lacking. Level of Evidence: 2